Wanbury Limited (BOM:524212)
India · Delayed Price · Currency is INR 230.70
-12.10 (-4.98%)
At close: Mar 27, 2026
Wanbury Market Cap
Wanbury has a market cap or net worth of 8.05 billion as of March 27, 2026. Its market cap has increased by 30.01% in one year.
Market Cap
8.05B
Enterprise Value
9.91B
Revenue
6.58B
Ranking
n/a
PE Ratio
12.00
Stock Price
230.70
Market Cap Chart
Since February 7, 2005, Wanbury's market cap has increased from 1.77B to 8.05B, an increase of 355.35%. That is a compound annual growth rate of 7.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 8.47B | 6.89% |
| Dec 31, 2025 | 7.93B | -17.28% |
| Dec 31, 2024 | 9.58B | 121.65% |
| Dec 29, 2023 | 4.32B | 169.44% |
| Dec 30, 2022 | 1.60B | -40.72% |
| Dec 31, 2021 | 2.71B | 135.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lincoln Pharmaceuticals | 11.95B |
| Venus Remedies | 11.79B |
| TTK Healthcare | 11.22B |
| Syncom Formulations (India) | 10.87B |
| Fermenta Biotech | 10.57B |
| Fredun Pharmaceuticals | 8.28B |
| Anuh Pharma | 7.16B |
| Bharat Parenterals | 6.84B |